Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scores

The Board Certified Psychiatric Pharmacist (BCPP) specialty certification was launched by the Board of Pharmacy Specialties in 1994. Candidates for the BCPP can qualify for the examination through 3 possible pathways: practice experience (4 years) in the specialty, completion of a PGY-1 residency pl...

Full description

Bibliographic Details
Published in:	Mental Health Clinician
Main Authors:	Timothy J. Muckle, PhD, Julie Dopheide, PharmD, BCPP, FASHP, Kelly Gable, PharmD, BCPP, Yu Meng, PhD, Samuel G. Johnson, PharmD, BCPS, William Ellis, MS, RPh
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2021-11-01
Subjects:	board certification psychometrics bcpp psychiatric pharmacy certification
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2021.11.358

Similar Items

Standardized reporting on studies of psychiatric pharmacist interventions
by: Brittany L. Parmentier, PharmD, MPH, BCPS, BCPP, et al.
Published: (2024-08-01)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)

Evaluation of workload among Board-Certified Psychiatric Pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, BCPP, FCCP, FASHP, et al.
Published: (2025-06-01)

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
by: Amber R. Douglass, PharmD, BCPS, BCPP, et al.
Published: (2024-08-01)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022-04-01)

Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
by: Samantha Catanzano, PharmD, BCPP, et al.
Published: (2025-06-01)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022-04-01)

Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements
by: Kelly C. Lee, PharmD, MAS, BCPP, et al.
Published: (2022-04-01)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023-01-01)

Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01)

A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients
by: Stephanie L. Hsia, PharmD, BCPP, MAEd, et al.
Published: (2025-08-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Increasing access to psychiatric care during the COVID-19 pandemic through mental health clinical pharmacy specialist services
by: Vickery P. Brittany PharmD, BCPS, BCPP, CPP, et al.
Published: (2023-08-01)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)

Survey of prescriptive authority among psychiatric pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, APh, BCPP, FCCP, et al.
Published: (2023-03-01)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Training student pharmacists to administer long-acting injectable medications
by: Megan J. Ehret, PharmD, MS, BCPP, et al.
Published: (2024-04-01)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021-01-01)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024-02-01)

Barriers to access to psychiatric medications in Missouri county jails
by: Burval Jessica K. PharmD, BCPP, et al.
Published: (2023-10-01)

Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
by: Kevin Chen, PharmD, et al.
Published: (2025-04-01)

Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitors
by: Kayla Johnson, PharmD, BCPS, BCPP
Published: (2024-12-01)

The impact of early direct-contact experiences on reducing mental health stigma among student pharmacists: A pilot study
by: Amber R. Tran, BS, et al.
Published: (2024-02-01)

Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
by: Sabrina Livezey, PharmD, CSP, et al.
Published: (2021-05-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023-08-01)

Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology
by: Loulwa Maktabi, PharmD, BCPS, et al.
Published: (2024-02-01)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022-11-01)

A scoping review of successful strategies for passing the American Board of Surgery certifying examination
by: Matthew D. Cahn, MD, et al.
Published: (2024-01-01)

Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023-01-01)

Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
by: Beth M. DeJongh, PharmD, BCPP, BCPS
Published: (2021-11-01)

Adopting an Advanced Community Pharmacy Practice Experiential Educational Model Across Colleges of Pharmacy
by: Jennifer L. Rodis, Pharm.D., BCPS, et al.
Published: (2011-01-01)

Learning From Consultations Conducted by Community Pharmacists in Northern Ireland for Nonprescription Sildenafil: A Qualitative Study Using the Theoretical Domains Framework
by: Rineke Gordijn, PharmD, et al.
Published: (2021-12-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
by: Letitia N. Warunek, PharmD, BCPS, et al.
Published: (2024-06-01)

Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility
by: Bailey B. Bass, PharmD, BCPS, et al.
Published: (2024-02-01)

Coping, resilience, and emotional well-being in pharmacy students during the COVID-19 pandemic
by: Andrea V. Fuentes, PharmD, et al.
Published: (2021-09-01)